Cargando…
Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF
BACKGROUND: Skeletal muscle (SM) alterations contribute to exercise intolerance in heart failure patients with preserved (HFpEF) or reduced (HFrEF) left ventricular ejection fraction (LVEF). Protein degradation via the ubiquitin‐proteasome‐system (UPS), nuclear apoptosis, and reduced mitochondrial e...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318515/ https://www.ncbi.nlm.nih.gov/pubmed/33955206 http://dx.doi.org/10.1002/ehf2.13405 |
_version_ | 1783730262501228544 |
---|---|
author | Adams, Volker Wunderlich, Sebastian Mangner, Norman Hommel, Jennifer Esefeld, Katrin Gielen, Stephan Halle, Martin Ellingsen, Øyvind Van Craenenbroeck, Emeline M. Wisløff, Ulrik Pieske, Burkert Linke, Axel Winzer, Ephraim B. |
author_facet | Adams, Volker Wunderlich, Sebastian Mangner, Norman Hommel, Jennifer Esefeld, Katrin Gielen, Stephan Halle, Martin Ellingsen, Øyvind Van Craenenbroeck, Emeline M. Wisløff, Ulrik Pieske, Burkert Linke, Axel Winzer, Ephraim B. |
author_sort | Adams, Volker |
collection | PubMed |
description | BACKGROUND: Skeletal muscle (SM) alterations contribute to exercise intolerance in heart failure patients with preserved (HFpEF) or reduced (HFrEF) left ventricular ejection fraction (LVEF). Protein degradation via the ubiquitin‐proteasome‐system (UPS), nuclear apoptosis, and reduced mitochondrial energy supply is associated with SM weakness in HFrEF. These mechanisms are incompletely studied in HFpEF, and a direct comparison between these groups is missing. METHODS AND RESULTS: Patients with HFpEF (LVEF ≥ 50%, septal E/e′ > 15 or >8 and NT‐proBNP > 220 pg/mL, n = 20), HFrEF (LVEF ≤ 35%, n = 20) and sedentary control subjects (Con, n = 12) were studied. Inflammatory markers were measured in serum, and markers of the UPS, nuclear apoptosis, and energy metabolism were determined in percutaneous SM biopsies. Both HFpEF and HFrEF showed increased proteolysis (MuRF‐1 protein expression, ubiquitination, and proteasome activity) with proteasome activity significantly related to interleukin‐6. Proteolysis was more pronounced in patients with lower exercise capacity as indicated by peak oxygen uptake in per cent predicted below the median. Markers of apoptosis did not differ between groups. Mitochondrial energy supply was reduced in HFpEF and HFrEF (complex‐I activity: −31% and −53%; malate dehydrogenase activity: −20% and −29%; both P < 0.05 vs. Con). In contrast, short‐term energy supply via creatine kinase was increased in HFpEF but decreased in HFrEF (47% and −45%; P < 0.05 vs. Con). CONCLUSIONS: Similarly to HFrEF, skeletal muscle in HFpEF is characterized by increased proteolysis linked to systemic inflammation and reduced exercise capacity. Energy metabolism is disturbed in both groups; however, its regulation seems to be severity‐dependent. |
format | Online Article Text |
id | pubmed-8318515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83185152021-07-31 Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF Adams, Volker Wunderlich, Sebastian Mangner, Norman Hommel, Jennifer Esefeld, Katrin Gielen, Stephan Halle, Martin Ellingsen, Øyvind Van Craenenbroeck, Emeline M. Wisløff, Ulrik Pieske, Burkert Linke, Axel Winzer, Ephraim B. ESC Heart Fail Original Research Articles BACKGROUND: Skeletal muscle (SM) alterations contribute to exercise intolerance in heart failure patients with preserved (HFpEF) or reduced (HFrEF) left ventricular ejection fraction (LVEF). Protein degradation via the ubiquitin‐proteasome‐system (UPS), nuclear apoptosis, and reduced mitochondrial energy supply is associated with SM weakness in HFrEF. These mechanisms are incompletely studied in HFpEF, and a direct comparison between these groups is missing. METHODS AND RESULTS: Patients with HFpEF (LVEF ≥ 50%, septal E/e′ > 15 or >8 and NT‐proBNP > 220 pg/mL, n = 20), HFrEF (LVEF ≤ 35%, n = 20) and sedentary control subjects (Con, n = 12) were studied. Inflammatory markers were measured in serum, and markers of the UPS, nuclear apoptosis, and energy metabolism were determined in percutaneous SM biopsies. Both HFpEF and HFrEF showed increased proteolysis (MuRF‐1 protein expression, ubiquitination, and proteasome activity) with proteasome activity significantly related to interleukin‐6. Proteolysis was more pronounced in patients with lower exercise capacity as indicated by peak oxygen uptake in per cent predicted below the median. Markers of apoptosis did not differ between groups. Mitochondrial energy supply was reduced in HFpEF and HFrEF (complex‐I activity: −31% and −53%; malate dehydrogenase activity: −20% and −29%; both P < 0.05 vs. Con). In contrast, short‐term energy supply via creatine kinase was increased in HFpEF but decreased in HFrEF (47% and −45%; P < 0.05 vs. Con). CONCLUSIONS: Similarly to HFrEF, skeletal muscle in HFpEF is characterized by increased proteolysis linked to systemic inflammation and reduced exercise capacity. Energy metabolism is disturbed in both groups; however, its regulation seems to be severity‐dependent. John Wiley and Sons Inc. 2021-05-05 /pmc/articles/PMC8318515/ /pubmed/33955206 http://dx.doi.org/10.1002/ehf2.13405 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Articles Adams, Volker Wunderlich, Sebastian Mangner, Norman Hommel, Jennifer Esefeld, Katrin Gielen, Stephan Halle, Martin Ellingsen, Øyvind Van Craenenbroeck, Emeline M. Wisløff, Ulrik Pieske, Burkert Linke, Axel Winzer, Ephraim B. Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title | Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title_full | Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title_fullStr | Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title_full_unstemmed | Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title_short | Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF |
title_sort | ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with hfpef and hfref |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318515/ https://www.ncbi.nlm.nih.gov/pubmed/33955206 http://dx.doi.org/10.1002/ehf2.13405 |
work_keys_str_mv | AT adamsvolker ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT wunderlichsebastian ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT mangnernorman ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT hommeljennifer ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT esefeldkatrin ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT gielenstephan ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT hallemartin ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT ellingsenøyvind ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT vancraenenbroeckemelinem ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT wisløffulrik ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT pieskeburkert ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT linkeaxel ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref AT winzerephraimb ubiquitinproteasomesystemandenzymesofenergymetabolisminskeletalmuscleofpatientswithhfpefandhfref |